Metraipolis › archive › dc_9e4310d87f8f
Combinatorial BCL2/BCL2L1 expression predicts clinical response to ruxolitinib in myelofibrosis — Europe PMC PMID:41287119
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41287119
- DOI
- 10.1186/s40364-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T07:23:23.495Z
- SHA-256 of the archived text
c49bef494fdc7d8d2262ae3dadb373ff9799c2346080d0c804783facf89c9636- Stable URL of this page
https://metraipolis.com/documento/dc_9e4310d87f8f
How to cite
Combinatorial BCL2/BCL2L1 expression predicts clinical response to ruxolitinib in myelofibrosis — Europe PMC PMID:41287119 — Europe PMC (en), https://europepmc.org/article/MED/41287119 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9e4310d87f8f (Metraipolis archive dc_9e4310d87f8f, sha256 c49bef494fdc7d8d2262ae3dadb373ff9799c2346080d0c804783facf89c9636)
BibTeX
@misc{dc9e4310d87f8f,
title = {Combinatorial BCL2/BCL2L1 expression predicts clinical response to ruxolitinib in myelofibrosis — Europe PMC PMID:41287119},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41287119},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9e4310d87f8f; sha256 c49bef494fdc7d8d2262ae3dadb373ff9799c2346080d0c804783facf89c9636},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41287119. Agents can read the archived copy with the MCP tool read_document.